Page last updated: 2024-12-11
2'-amino-2'-deoxyuridine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
2'-amino-2'-deoxyuridine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 6482479 |
| CHEMBL ID | 2032102 |
| SCHEMBL ID | 574878 |
| MeSH ID | M0365712 |
Synonyms (21)
| Synonym |
|---|
| 2,4(1h,3h)-pyrimidinedione, 1-(2-amino-2-deoxy-b-d-ribofuranosyl)- |
| 1-[(2r,3r,4s,5r)-3-amino-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione |
| 1-[(2r,3r,4s,5r)-3-amino-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione |
| 26889-39-4 |
| CHEMBL2032102 |
| AKOS016003848 |
| HG1154 |
| 2'-amino-2'-deoxyuridine |
| SCHEMBL574878 |
| LLIPTMWIZVIUSX-XVFCMESISA-N |
| 2'-amino-2'-deoxy uridine |
| 2'-amino,2'-deoxyuridine |
| DTXSID70424315 |
| mfcd01317284 |
| 1-[(2r,3r,4s,5r)-3-amino-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione |
| AS-59094 |
| 2'-deoxy-2'-amino-uridine |
| 2-amino-2-deoxyuridine |
| CS-W014134 |
| A855492 |
| 1-(2-amino-2-deoxy-beta-d-ribofuranosyl)uracil; |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (1)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID662565 | Growth inhibition of Trichomonas vaginalis T1 at 100 uM after 24 hrs by hemocytometry | 2012 | Bioorganic & medicinal chemistry letters, Jun-15, Volume: 22, Issue:12 | S-Adenosylhomocysteine hydrolase of the protozoan parasite Trichomonas vaginalis: potent inhibitory activity of 9-(2-deoxy-2-fluoro-β,D-arabinofuranosyl)adenine. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.70
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.70) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||